Federal Register
Medical Devices; Neurological Devices; Classification of the Prognostic Assessment Software of Mild Cognitive Impairment- Facts included
- The Food and Drug Administration (FDA) is classifying the prognostic assessment software of mild cognitive impairment into class II (special controls).
- The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the prognostic assessment software of mild cognitive impairment.
- Sourcing
- The information appears to come from a single FDA announcement; no additional independent sources are cited, limiting verification of claims beyond the agency's statement.
- Framing
- The text mixes factual reporting (classification decision) with evaluative language (e.g., "reasonable assurance of safety and effectiveness," "enhance patients' access," "reducing regulatory burdens"), which reflects an opinionated framing rather than pure reporting.
- Omissions
- The excerpt does not explain what specific special controls will apply, how the classification change will affect manufacturers, clinicians, or patients, nor does it provide data on the safety or effectiveness of the software.
- Rhetorical notes (3)
- Appeal to Authority · Positive Framing · Future Benefit Claim